Joel Greenblatt - Gotham Asset Management
Holding/activity history for Meridian Bioscience Inc (MR4)
← All MR4 superinvestors
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2023 Q1 | 0 | 0.00 | Sell 100.00% | <0.01 | SEC | ||
| 2022 Q4 | 10,058 | <0.01 | Reduce 54.09% | 0.01 | $33.21 | $334,026 | SEC |
| 2022 Q3 | 21,908 | 0.02 | Buy | 0.02 | $31.54 | $691,000 | SEC |
| 2021 Q3 | 0 | 0.00 | Sell 100.00% | 0.04 | SEC | ||
| 2021 Q2 | 38,180 | 0.04 | Add 56.88% | 0.01 | $22.18 | $847,000 | SEC |
| 2021 Q1 | 24,337 | 0.03 | Reduce 25.31% | <0.01 | $26.26 | $639,000 | SEC |
| 2020 Q4 | 32,584 | 0.02 | Add 161.03% | 0.01 | $18.69 | $609,000 | SEC |
| 2020 Q3 | 12,483 | <0.01 | Add 6.36% | <0.01 | $16.98 | $212,000 | SEC |
| 2020 Q2 | 11,737 | <0.01 | Reduce 15.15% | <0.01 | $23.26 | $273,000 | SEC |
| 2020 Q1 | 13,833 | <0.01 | Buy | <0.01 | $8.39 | $116,000 | SEC |
| 2019 Q4 | 0 | 0.00 | Sell 100.00% | <0.01 | SEC | ||
| 2019 Q3 | 20,438 | <0.01 | Reduce 36.83% | <0.01 | $9.49 | $194,000 | SEC |
| 2019 Q2 | 32,353 | <0.01 | Reduce 2.74% | <0.01 | $11.87 | $384,000 | SEC |
| 2019 Q1 | 33,263 | <0.01 | Add 87.42% | <0.01 | $17.62 | $586,000 | SEC |
| 2018 Q4 | 17,748 | <0.01 | Reduce 26.92% | <0.01 | $17.35 | $308,000 | SEC |
| 2018 Q3 | 24,286 | <0.01 | Reduce 7.98% | <0.01 | $14.91 | $362,000 | SEC |
| 2018 Q2 | 26,393 | <0.01 | Reduce 36.15% | <0.01 | $15.91 | $420,000 | SEC |
| 2018 Q1 | 41,334 | <0.01 | Reduce 74.15% | 0.02 | $14.20 | $587,000 | SEC |
| 2017 Q4 | 159,916 | 0.03 | Reduce 18.50% | <0.01 | $14.00 | $2,239,000 | SEC |
| 2017 Q3 | 196,214 | 0.04 | Reduce 8.41% | <0.01 | $14.30 | $2,806,000 | SEC |
| 2017 Q2 | 214,227 | 0.05 | Reduce 8.56% | <0.01 | $15.75 | $3,374,000 | SEC |
| 2017 Q1 | 234,281 | 0.04 | Add 10.89% | <0.01 | $13.80 | $3,233,000 | SEC |
| 2016 Q4 | 211,281 | 0.05 | Reduce 14.43% | <0.01 | $17.70 | $3,740,000 | SEC |
| 2016 Q3 | 246,898 | 0.06 | Reduce 6.57% | <0.01 | $19.29 | $4,763,000 | SEC |
| 2016 Q2 | 264,250 | 0.06 | Add 54.37% | 0.02 | $19.50 | $5,153,000 | SEC |
| 2016 Q1 | 171,177 | 0.04 | Add 97.95% | 0.02 | $20.61 | $3,528,000 | SEC |
| 2015 Q4 | 86,476 | 0.02 | Reduce 52.50% | 0.02 | $20.51 | $1,774,000 | SEC |
| 2015 Q3 | 182,068 | 0.03 | Reduce 32.89% | 0.01 | $17.10 | $3,113,000 | SEC |
| 2015 Q2 | 271,315 | 0.04 | Reduce 4.15% | <0.01 | $18.64 | $5,057,000 | SEC |
| 2015 Q1 | 283,062 | 0.04 | Add 376.24% | 0.03 | $19.08 | $5,401,000 | SEC |
| 2014 Q4 | 59,437 | <0.01 | Add 10.83% | <0.01 | $16.45 | $978,000 | SEC |
| 2014 Q3 | 53,627 | <0.01 | Reduce 13.00% | <0.01 | $17.70 | $949,000 | SEC |
| 2014 Q2 | 61,641 | 0.02 | Reduce 0.51% | <0.01 | $20.64 | $1,272,000 | SEC |
| 2014 Q1 | 61,960 | 0.02 | Reduce 46.03% | 0.04 | $21.79 | $1,350,000 | SEC |
| 2013 Q4 | 114,807 | 0.08 | Reduce 26.08% | 0.03 | $26.53 | $3,046,000 | SEC |
| 2013 Q3 | 155,306 | 0.13 | Add 85.08% | 0.06 | $23.63 | $3,670,000 | SEC |
| 2013 Q2 | 83,913 | 0.08 | Add 31.32% | 0.02 | $21.50 | $1,804,000 | SEC |
| 2013 Q1 | 63,898 | 0.08 | Add 7.87% | <0.01 | $22.82 | $1,458,000 | SEC |
| 2012 Q4 | 59,236 | 0.07 | Add 6.14% | <0.01 | $20.26 | $1,200,000 | SEC |
| 2012 Q3 | 55,811 | 0.08 | Add 237.00% | 0.05 | $19.17 | $1,070,000 | SEC |
| 2012 Q2 | 16,561 | 0.03 | Buy | 0.03 | $20.47 | $339,000 | SEC |